Given our transcriptome data, we suggest that both IGHV mutated and IGHV unmutated CLL cells respond similarly on BCR triggering, and that the difference observed in freshly isolated peripheral blood CLL cells reflects a difference in in vivo triggering of the BCR. The gene discussed is BCR; the disease is B-cell chronic lymphocytic leukemia.